Vjhemonc Video Journal Of Hematology Hemonc

Optimizing post-CAR T-cell monitoring in lymphoma: evidence with the use of liso-cel 05:43
Optimizing post-CAR T-cell monitoring in lymphoma: evidence with the use of liso-cel VJHemOnc – Video Journal of Hematology & HemOnc 5 2 часа назад
Highlights in NHL and CLL from ASCO 2025: key trial updates 02:57
Highlights in NHL and CLL from ASCO 2025: key trial updates VJHemOnc – Video Journal of Hematology & HemOnc 1 55 лет назад
Practice-changing findings in MPNs from ASCO 2025 00:57
Practice-changing findings in MPNs from ASCO 2025 VJHemOnc – Video Journal of Hematology & HemOnc 4 1 час назад
Developing strategies for managing patients who relapse after CD19 CAR-T & CD20 bispecifics 01:44
Developing strategies for managing patients who relapse after CD19 CAR-T & CD20 bispecifics VJHemOnc – Video Journal of Hematology & HemOnc 4 55 лет назад
A Phase II trial of modakafusp alfa monotherapy in multiple myeloma 02:50
A Phase II trial of modakafusp alfa monotherapy in multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 21 21 час назад
Long-term outcomes from the BelaRd trial and the evaluation of a VRA tool to guide belamaf dosing 02:38
Long-term outcomes from the BelaRd trial and the evaluation of a VRA tool to guide belamaf dosing VJHemOnc – Video Journal of Hematology & HemOnc 2 2 часа назад
The new era of imaging in myeloma: combining 3 T whole-body MRI and 18F-FDG PET/CT 02:03
The new era of imaging in myeloma: combining 3 T whole-body MRI and 18F-FDG PET/CT VJHemOnc – Video Journal of Hematology & HemOnc 68 1 день назад
Welcome to the Video Journal of Hematology & Hematological Oncology 🩸 03:08
Welcome to the Video Journal of Hematology & Hematological Oncology 🩸 VJHemOnc – Video Journal of Hematology & HemOnc 1,463 11 месяцев назад
Novel targeting of S100A9 with tasquinimod in multiple myeloma 03:13
Novel targeting of S100A9 with tasquinimod in multiple myeloma VJHemOnc – Video Journal of Hematology & HemOnc 25 22 часа назад
Key factors that influence conditioning intensity and moving toward personalized conditioning in AML 03:56
Key factors that influence conditioning intensity and moving toward personalized conditioning in AML VJHemOnc – Video Journal of Hematology & HemOnc 20 1 день назад
Results from the VERIFY trial: the encouraging efficacy of rusfertide in patients with PV 02:32
Results from the VERIFY trial: the encouraging efficacy of rusfertide in patients with PV VJHemOnc – Video Journal of Hematology & HemOnc 19 1 день назад
Improving patient selection for immunotherapies in the future using biomarkers & resistance patterns 00:49
Improving patient selection for immunotherapies in the future using biomarkers & resistance patterns VJHemOnc – Video Journal of Hematology & HemOnc 14 22 часа назад
The potential use of multi-virus-specific T-cells to enhance the activity of bispecifics in lymphoma 02:41
The potential use of multi-virus-specific T-cells to enhance the activity of bispecifics in lymphoma VJHemOnc – Video Journal of Hematology & HemOnc 27 1 день назад
Challenges that exist in bringing CAR T-cell therapy to more patients with R/R lymphoma 01:32
Challenges that exist in bringing CAR T-cell therapy to more patients with R/R lymphoma VJHemOnc – Video Journal of Hematology & HemOnc 43 1 день назад
Long-term safety and efficacy of tagraxofusp in BPDCN: results from a subgroup analysis 01:48
Long-term safety and efficacy of tagraxofusp in BPDCN: results from a subgroup analysis VJHemOnc – Video Journal of Hematology & HemOnc 13 22 часа назад
The IMproveMF study: combining imetelstat with ruxolitinib for the treatment of myelofibrosis 00:58
The IMproveMF study: combining imetelstat with ruxolitinib for the treatment of myelofibrosis VJHemOnc – Video Journal of Hematology & HemOnc 209 22 часа назад
A myeloablative fractionated busulfan conditioning regimen with sorafenib for alloSCT in AML 07:35
A myeloablative fractionated busulfan conditioning regimen with sorafenib for alloSCT in AML VJHemOnc – Video Journal of Hematology & HemOnc 23 1 день назад
Immune checkpoint inhibitors in acute leukemia 09:55
Immune checkpoint inhibitors in acute leukemia VJHemOnc – Video Journal of Hematology & HemOnc 106 4 года назад
Kenneth Anderson: What are the next steps to a myeloma cure? 04:01
Kenneth Anderson: What are the next steps to a myeloma cure? VJHemOnc – Video Journal of Hematology & HemOnc 958 5 лет назад
Five-year follow-up of SEQUOIA Arm C: zanubrutinib in patients with del(17p) CLL 02:12
Five-year follow-up of SEQUOIA Arm C: zanubrutinib in patients with del(17p) CLL VJHemOnc – Video Journal of Hematology & HemOnc 75 2 дня назад

Сейчас ищут